Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)
Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)
Source: investorideas.com
Page 2 - Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ancer Immunotherapy Today - Breaking & Trending Today
Global Immuno-oncology Market Projected at $ 396 Billion by
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
New immunotherapy borrows cancer's tricks to unleash powerful T cells
Immunotherapies using engineered T cells have ushered in a new era in cancer treatment, but they have their limits. They may cause side effects or stop working, and they do not work at all against 90% of cancers.
Source: news-medical.net
Merck posts better-than-expected quarterly results on soaring Keytruda sales
(Reuters) -Merck & Co reported better-than-expected fourth-quarter results on Thursday on strong sales of its cancer immunotherapy Keytruda, now the world's biggest selling prescription medicine. Keytruda sales rose 21% to $6.6 billion as the company was able to increase use of the drug in earlier stage cancers, topping analyst forecasts of $6.5 billion. For the full year, Keytruda generated $25 billion, surpassing sales of AbbVie's blockbuster arthritis drug Humira at its peak.
Source: yahoo.com
Immuno-Oncology Market Poised for Substantial Growth,
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com